{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2a","columns":[{"gene":"","key":"population-33968f7806b86f98afe8","label":"Muscular dystrophy, limb-girdle, type 2A","mondoId":"MONDO:0009675","onsetQualifier":null,"originColumnKey":"MONDO:0009675/OMIM:253600","originalViews":[{"key":"MONDO:0009675/OMIM:253600","label":"Muscular dystrophy, limb-girdle, type 2A","scopeLabel":"OMIM:253600","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["083b66768ecb6db3d833c169ee1f06a2f6bff0ef19ae6a87607495dc4636bc01","3e4978725d72997162a921df96e4cdbe169450364b35f01bdbf20fbff430f249","43ce0a4f83688b2b978f2c9b21d9f342682dbd91554db4500a22926aad1c3afe","485a9d88e92c4eaf871a5577df041f36bb731a7e543f3af98ab83fab956c7c37","506f4a65faa4981123055d9c4abc24ace65cc4a8a3f2257c9cb1a68b42b2212e","5552dc80808cf06c7ca8534500caf6a511bdd1c48692df2c7435123989616b57","860659d2d5f82e3386f0e5cbee0cb97d0fbee943a04a5448a3208a4c15b242fd","9d50d3cb4ac5725a46047377acdaeff953d08019cc9d833c203d8894b45de80b","bc2434517b2ae918b259b27de7d494989fc6a4e01e651f89024938d3c92518fc","e877d00cce740358bebcb91381707f804ded0aa91e471961d9623348174cc421","f49e2f49715fff24567eb378cb9bfcf0d5500a49eeff0376ca2409b3d99256f0","f4d3aafc9b6bfcfde9b006aeb83fb3a90eff6ca043bfdee4a7c197319cb443ef"],"recordQualifiers":{},"scopeLabel":"OMIM:253600","sourceIds":["OMIM:253600"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-f0145397b35f420cb722","label":"Calpain-3-related limb-girdle muscular dystrophy R1","mondoId":"MONDO:0009675","onsetQualifier":null,"originColumnKey":"MONDO:0009675/ORPHA:267","originalViews":[{"key":"MONDO:0009675/ORPHA:267","label":"Calpain-3-related limb-girdle muscular dystrophy R1","scopeLabel":"ORPHA:267","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["072dba947ed065f10c2c16b5df66f7f14335b9639d56ca7e73f9b1b0185161f2","074b5c41ded1432af4633f7b62ed528ada580a700de2f9b78a394ed3641ada0e","2a5e3da58347a30f10c2c2a192bdbd27d13149c9c449ba0e9fbc6cff5e83a26e","45e87e2b56ced7c2ca163ebdc9350291d3bff75123245667f2177bbfaffa51a6","525dce369a8a340c1414692ee75adad9ec3c3e4ac55fad5bd9b461206050087f","5341ee792bb155eb17cf6b49d54e31a921d7cca0b93d2ef55e7c1a5666fd809a","54c6f5fe1b7e90c6844da20743711a11117633190302ae21cad5fbb0f4d99875","65479eedab59e6974ac7536277417b40668b0fd4e010e44a4f7bf9c5025014f4","87880df4abaa53b88c8326b0f9aaa4d36e6b876e41831bf6ae11e685c3199c1c","89f7f493dee3d11fcf627a56ad4634e3f9e381d38ecd8d6998ecb6d1c65b7c6e","9dd1366658e36477d81f6c458b9dfc26cd7859fe61ae99da493117a0cd4a5820","a8080a96641eb0024a073ab5648d7658ae660bfdedf886f7668e7ddf01d5cdbf","a946df654c14dcdd5080c00095fb572c034e5b53fd34e4a512ada877a7025766","a9f1e2929b81d4a48884836dd0503f4bc4bb0eab71acf71d038ea0fed13de1db","ae1277eb9cad25728e4f9905ee919c7d66809f85d8a656917b1c226938f351e4","ae700dc2b0b3f44e9cae659f5e8dfe9600874587519579e54855bd758d219e2c","afa83077b9317e7ec11875b4e71627a4f71dfac18e1331116457d90ca144fb26","d68c9fe2d19af3ace58c632124c5043ac9f68c690a0655fdbe99797fd79571d0","db18e7165df6b5314d2857e697fb3e6dd19a6775ae99ec1403ea950b717cdce7","e8094cf50bd1eb5d218136380cda0e8ec4c78fdad91a7b9ec9e29deee9199698","f5bb1342438ccdf7927bb64fb1b301db123d1269b36ae4819fdc52d6c3af37f1"],"recordQualifiers":{},"scopeLabel":"ORPHA:267","sourceIds":["ORPHA:267"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-33968f7806b86f98afe8","population-f0145397b35f420cb722"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0006466","HP:0008981","HP:0002312","HP:0005879","HP:0003551","HP:0002987","HP:0003236"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":33,"sourceGroups":{"omim":5,"orphanet":21,"published":7}},"features":[{"hpoId":"HP:0006466","label":"Ankle flexion contracture","primary":true},{"hpoId":"HP:0008981","label":"Calf muscle hypertrophy","primary":true},{"hpoId":"HP:0002312","label":"Clumsiness","primary":true},{"hpoId":"HP:0005879","label":"Congenital finger flexion contractures","primary":true},{"hpoId":"HP:0003551","label":"Difficulty climbing stairs","primary":true},{"hpoId":"HP:0002987","label":"Elbow flexion contracture","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0010628","label":"Facial palsy","primary":false},{"hpoId":"HP:0001371","label":"Flexion contracture","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0003324","label":"Generalized muscle weakness","primary":false},{"hpoId":"HP:0003089","label":"Hamstring contractures","primary":false},{"hpoId":"HP:0003307","label":"Hyperlordosis","primary":false},{"hpoId":"HP:0001880","label":"Increased total eosinophil count","primary":false},{"hpoId":"HP:0007340","label":"Lower limb muscle weakness","primary":false},{"hpoId":"HP:0032019","label":"Muscle eosinophilia","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0100614","label":"Myositis","primary":false},{"hpoId":"HP:0012037","label":"Pectoralis amyotrophy","primary":false},{"hpoId":"HP:0008946","label":"Pelvic girdle amyotrophy","primary":false},{"hpoId":"HP:0007126","label":"Proximal amyotrophy","primary":false},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":false},{"hpoId":"HP:0009060","label":"Scapular muscle atrophy","primary":false},{"hpoId":"HP:0003691","label":"Scapular winging","primary":false},{"hpoId":"HP:0003306","label":"Spinal rigidity","primary":false},{"hpoId":"HP:0030051","label":"Tip-toe gait","primary":false},{"hpoId":"HP:0001239","label":"Wrist flexion contracture","primary":false}],"ledeHtml":"Calpain-3-related limb-girdle muscular dystrophy R1 (also known as LGMD2A) is an autosomal recessive limb-girdle muscular dystrophy characterized by progressive, symmetrical weakness of the proximal limb and girdle muscles (mainly those around the hips and shoulders) without heart involvement or intellectual disability. The condition is caused by genetic changes in the CAPN3 gene. LGMD2A is the most common form of limb-girdle muscular dystrophy, accounting for about 30 percent of cases. LGMD2A is also known as primary calpainopathy. Calpainopathies are diseases caused by genetic changes in the CAPN3 gene and can be autosomal recessive or autosomal dominant. Pelvifemoral limb-girdle muscular dystrophy (also known as Leyden-Mobius LGMD) is the most frequently observed subtype. In these cases, muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle. In most cases, muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle; HyperCKemia is usually observed in children or young individuals. In most cases, those affected do not have symptoms, just high levels of creatine kinase in their blood.","mondoId":"MONDO:0009675","node":{"canonicalSlug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2a","comparisons":[{"documentSha256":"6a6ea8af2f70fbd3825040b63591d9214825280c493ce7b8536ed4cac9380b03","key":"legacy-limb-girdle-muscular-dystrophy","kind":"legacy","label":"limb-girdle muscular dystrophy","memberIds":["MONDO:0009675","MONDO:0012034","MONDO:0012127","MONDO:0012193","MONDO:0012652","MONDO:0013297","MONDO:0014782","MONDO:0014788","MONDO:0014900","MONDO:0014977","MONDO:0016971","MONDO:0021018","MONDO:0029133","MONDO:0030014","MONDO:0030456","MONDO:0035432","MONDO:0957270","MONDO:0971171"],"mondoId":"MONDO:0016971","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/limb-girdle-muscular-dystrophy.6a6ea8af2f70fbd3825040b63591d9214825280c493ce7b8536ed4cac9380b03.json"},{"documentSha256":"44b063290da75047b19d620af1a4fbd71bbfc833ba8d796f6bf3f1cbd2384659","key":"expanded-limb-girdle-muscular-dystrophy","kind":"expanded","label":"limb-girdle muscular dystrophy","memberIds":["MONDO:0009181","MONDO:0009675","MONDO:0009676","MONDO:0009677","MONDO:0009681","MONDO:0009683","MONDO:0011028","MONDO:0011170","MONDO:0011423","MONDO:0011787","MONDO:0011968","MONDO:0012034","MONDO:0012127","MONDO:0012193","MONDO:0012215","MONDO:0012248","MONDO:0012652","MONDO:0012699","MONDO:0013161","MONDO:0013162","MONDO:0013297","MONDO:0013390","MONDO:0013440","MONDO:0014142","MONDO:0014144","MONDO:0014474","MONDO:0014489","MONDO:0014782","MONDO:0014788","MONDO:0014900","MONDO:0014977","MONDO:0015151","MONDO:0015152","MONDO:0016971","MONDO:0018098","MONDO:0021018","MONDO:0021569","MONDO:0024530","MONDO:0029133","MONDO:0029135","MONDO:0029136","MONDO:0030014","MONDO:0030456","MONDO:0035432","MONDO:0957270","MONDO:0971171"],"mondoId":"MONDO:0016971","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-44b063290da75047b19d.44b063290da75047b19d620af1a4fbd71bbfc833ba8d796f6bf3f1cbd2384659.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal recessive limb-girdle muscular dystrophy type 2A","originalSourceId":"ORPHA:267","paragraphs":["Calpain-3-related limb-girdle muscular dystrophy R1 (also known as LGMD2A) is an autosomal recessive limb-girdle muscular dystrophy characterized by progressive, symmetrical weakness of the proximal limb and girdle muscles (mainly those around the hips and shoulders) without heart involvement or intellectual disability. The condition is caused by genetic changes in the CAPN3 gene. LGMD2A is the most common form of limb-girdle muscular dystrophy, accounting for about 30 percent of cases. LGMD2A is also known as primary calpainopathy. Calpainopathies are diseases caused by genetic changes in the CAPN3 gene and can be autosomal recessive or autosomal dominant. Pelvifemoral limb-girdle muscular dystrophy (also known as Leyden-Mobius LGMD) is the most frequently observed subtype. In these cases, muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle. In most cases, muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle; HyperCKemia is usually observed in children or young individuals. In most cases, those affected do not have symptoms, just high levels of creatine kinase in their blood."],"rawAttribution":"MONDO:0009675","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:25Z","upstream":"GARD:0001057","url":"https://rarediseases.info.nih.gov/diseases/1057"},"ownColumnKeys":["population-33968f7806b86f98afe8","population-f0145397b35f420cb722"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal recessive limb-girdle muscular dystrophy","mondoId":"MONDO:0015152","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"range","key":"072dba947ed065f10c2c16b5df66f7f14335b9639d56ca7e73f9b1b0185161f2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008981","is_excluded":false,"label":"Calf muscle hypertrophy","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"074b5c41ded1432af4633f7b62ed528ada580a700de2f9b78a394ed3641ada0e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003551","is_excluded":false,"label":"Difficulty climbing stairs","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"083b66768ecb6db3d833c169ee1f06a2f6bff0ef19ae6a87607495dc4636bc01","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003691","is_excluded":false,"label":"Scapular winging","onset_id":null,"reference":"OMIM:253600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"2a5e3da58347a30f10c2c2a192bdbd27d13149c9c449ba0e9fbc6cff5e83a26e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003691","is_excluded":false,"label":"Scapular winging","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3e4978725d72997162a921df96e4cdbe169450364b35f01bdbf20fbff430f249","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"PMID:16607617","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"43ce0a4f83688b2b978f2c9b21d9f342682dbd91554db4500a22926aad1c3afe","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0032019","is_excluded":false,"label":"Muscle eosinophilia","onset_id":null,"reference":"PMID:16607617","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"45e87e2b56ced7c2ca163ebdc9350291d3bff75123245667f2177bbfaffa51a6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"485a9d88e92c4eaf871a5577df041f36bb731a7e543f3af98ab83fab956c7c37","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"PCS","frequency_raw":"3/6","hpo_id":"HP:0001880","is_excluded":false,"label":"Increased total eosinophil count","onset_id":null,"reference":"PMID:16607617","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"506f4a65faa4981123055d9c4abc24ace65cc4a8a3f2257c9cb1a68b42b2212e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:16607617","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"525dce369a8a340c1414692ee75adad9ec3c3e4ac55fad5bd9b461206050087f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008946","is_excluded":false,"label":"Pelvic girdle amyotrophy","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5341ee792bb155eb17cf6b49d54e31a921d7cca0b93d2ef55e7c1a5666fd809a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0009060","is_excluded":false,"label":"Scapular muscle atrophy","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"54c6f5fe1b7e90c6844da20743711a11117633190302ae21cad5fbb0f4d99875","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5552dc80808cf06c7ca8534500caf6a511bdd1c48692df2c7435123989616b57","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007126","is_excluded":false,"label":"Proximal amyotrophy","onset_id":null,"reference":"OMIM:253600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"65479eedab59e6974ac7536277417b40668b0fd4e010e44a4f7bf9c5025014f4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001239","is_excluded":false,"label":"Wrist flexion contracture","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"860659d2d5f82e3386f0e5cbee0cb97d0fbee943a04a5448a3208a4c15b242fd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"PCS","frequency_raw":"2/6","hpo_id":"HP:0007340","is_excluded":false,"label":"Lower limb muscle weakness","onset_id":null,"reference":"PMID:16607617","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"87880df4abaa53b88c8326b0f9aaa4d36e6b876e41831bf6ae11e685c3199c1c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"89f7f493dee3d11fcf627a56ad4634e3f9e381d38ecd8d6998ecb6d1c65b7c6e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003324","is_excluded":false,"label":"Generalized muscle weakness","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"9d50d3cb4ac5725a46047377acdaeff953d08019cc9d833c203d8894b45de80b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0100614","is_excluded":false,"label":"Myositis","onset_id":null,"reference":"PMID:16607617","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"9dd1366658e36477d81f6c458b9dfc26cd7859fe61ae99da493117a0cd4a5820","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001371","is_excluded":false,"label":"Flexion contracture","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a8080a96641eb0024a073ab5648d7658ae660bfdedf886f7668e7ddf01d5cdbf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030051","is_excluded":false,"label":"Tip-toe gait","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a946df654c14dcdd5080c00095fb572c034e5b53fd34e4a512ada877a7025766","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007340","is_excluded":false,"label":"Lower limb muscle weakness","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a9f1e2929b81d4a48884836dd0503f4bc4bb0eab71acf71d038ea0fed13de1db","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003089","is_excluded":false,"label":"Hamstring contractures","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ae1277eb9cad25728e4f9905ee919c7d66809f85d8a656917b1c226938f351e4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003306","is_excluded":false,"label":"Spinal rigidity","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ae700dc2b0b3f44e9cae659f5e8dfe9600874587519579e54855bd758d219e2c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005879","is_excluded":false,"label":"Congenital finger flexion contractures","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"afa83077b9317e7ec11875b4e71627a4f71dfac18e1331116457d90ca144fb26","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012037","is_excluded":false,"label":"Pectoralis amyotrophy","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc2434517b2ae918b259b27de7d494989fc6a4e01e651f89024938d3c92518fc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010628","is_excluded":false,"label":"Facial palsy","onset_id":null,"reference":"OMIM:253600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d68c9fe2d19af3ace58c632124c5043ac9f68c690a0655fdbe99797fd79571d0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003307","is_excluded":false,"label":"Hyperlordosis","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"db18e7165df6b5314d2857e697fb3e6dd19a6775ae99ec1403ea950b717cdce7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002987","is_excluded":false,"label":"Elbow flexion contracture","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e8094cf50bd1eb5d218136380cda0e8ec4c78fdad91a7b9ec9e29deee9199698","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e877d00cce740358bebcb91381707f804ded0aa91e471961d9623348174cc421","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"OMIM:253600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f49e2f49715fff24567eb378cb9bfcf0d5500a49eeff0376ca2409b3d99256f0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001371","is_excluded":false,"label":"Flexion contracture","onset_id":null,"reference":"OMIM:253600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"f4d3aafc9b6bfcfde9b006aeb83fb3a90eff6ca043bfdee4a7c197319cb443ef","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:253600","disease_name":"Muscular dystrophy, limb-girdle, type 2A","evidence":"PCS","frequency_raw":"2/6","hpo_id":"HP:0002312","is_excluded":false,"label":"Clumsiness","onset_id":null,"reference":"PMID:16607617","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f5bb1342438ccdf7927bb64fb1b301db123d1269b36ae4819fdc52d6c3af37f1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:267","disease_name":"Calpain-3-related limb-girdle muscular dystrophy R1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0006466","is_excluded":false,"label":"Ankle flexion contracture","onset_id":null,"reference":"ORPHA:267","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/1057\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009675\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0001057</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Calpain-3-related limb-girdle muscular dystrophy R1 (also known as LGMD2A) is an autosomal recessive limb-girdle muscular dystrophy characterized by progressive, symmetrical weakness of the proximal limb and girdle muscles (mainly those around the hips and shoulders) without heart involvement or intellectual disability. The condition is caused by genetic changes in the CAPN3 gene. LGMD2A is the most common form of limb-girdle muscular dystrophy, accounting for about 30 percent of cases. LGMD2A is also known as primary calpainopathy. Calpainopathies are diseases caused by genetic changes in the CAPN3 gene and can be autosomal recessive or autosomal dominant. Pelvifemoral limb-girdle muscular dystrophy (also known as Leyden-Mobius LGMD) is the most frequently observed subtype. In these cases, muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle. In most cases, muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle; HyperCKemia is usually observed in children or young individuals. In most cases, those affected do not have symptoms, just high levels of creatine kinase in their blood.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/1057\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2a","sourceDocuments":[{"name":"GARD: Autosomal recessive limb-girdle muscular dystrophy type 2A","reviewed":null,"source_release":"2026-10-25T03:38:25Z","url":"https://rarediseases.info.nih.gov/diseases/1057"},{"name":"MONDO: autosomal recessive limb-girdle muscular dystrophy type 2A","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009675"}],"sourceNote":"","synonyms":["autosomal recessive limb-girdle muscular dystrophy caused by mutation in CAPN3","autosomal recessive limb-girdle muscular dystrophy type 2A","calpainopathy","CAPN3 autosomal recessive limb-girdle muscular dystrophy","Leyden-Moebius muscular dystrophy","LGMD2","LGMD2A","limb-girdle muscular dystrophy due to calpain deficiency","limb-girdle muscular dystrophy type 2","limb-girdle muscular dystrophy type 2A","muscular dystrophy limb girdle type 2A, erb type","muscular dystrophy, limb-girdle, autosomal recessive 1","muscular dystrophy, limb-girdle, type 2A","primary calpainopathy"],"takeawayHtml":"","title":"autosomal recessive limb-girdle muscular dystrophy type 2A"},"schemaVersion":1}
